CIBC Bancorp USA’s Prestige Consumer Healthcare PBH Stock Holding History

CIBC Bancorp USA’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$329K	Buy	+5,276	New	+$367K	﹤0.01%	1042

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

CIBC Bancorp USA's PBH Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Prestige Consumer Healthcare (PBH) in Q3 2025: 5,276 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.

356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

CIBC Bancorp USA held 5,276 shares of Prestige Consumer Healthcare worth $329K as of Q3 2025.
Prestige Consumer Healthcare was a new CIBC Bancorp USA position in Q3 2025.
Prestige Consumer Healthcare made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1042 holding.
356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.